Background Historically, lack of data on cost-effectiveness of influenza vaccination has been
identified as a barrier to vaccine use in low-and middle-income countries. We conducted a …

Vaccines developed in high-income countries have been enormously successful in reducing
the global burden of infectious diseases, saving perhaps 2.5 million lives per year, but even …

Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of
building a global system that can support both routine and pandemic/epidemic adult …

Background Competing priorities make using a transparent and evidence-based approach
important when deciding to recommend new vaccines. We conducted a literature review to …

Africa has the highest incidence of mortality caused by infectious diseases, and remarkably
does not have the capacity to manufacture vaccines that are essential to reduce mortality …

Immunizing pregnant women is a promising strategy to reduce infectious disease-related
morbidity and mortality in pregnant women and their infants. Important pre-requisites for the …

Many industrialized countries have implemented routine immunization policies for older
adults, but similar strategies have not been widely implemented in low-and middle-income …

Vaccines have already saved many lives and they have the potential to save many more as
increasingly elaborate technologies deliver new and effective vaccines against both …

As more new and improved vaccines become available, decisions on which to adopt into
routine programmes become more frequent and complex. This qualitative study aimed to …

Vaccine research and development are experiencing a renaissance of interest from the
global scientific community. There are four major reasons for this:(1) the lack of efficacious …